The global market for point-of-care testing (poct) is expected to grow from $ 23,044.4 million in 2021 to $ 36,112.0 million in 2026. The market is expected to grow at a CAGR of 9.4% over the forecast period (2021-2026). Some of the market's key participants are A. Menarini Diagnostics, ARKRAY, Abaxis (Zoetis), Abbott, Accriva, Alfa Wassermann, Ascensia, Bio-Rad Laboratories, BioMerieux, Chembio Diagnostics, Danaher, ELITech Group, Helena Laboratories, Johnson & Johnson, Nova Biomedical, OraSure Technologies, Ortho Clinical Diagnostics, Phamatech, Princeton BioMeditech, Quidel, Response Biomedical, Roche, Siemens Healthcare, Trinity Biotech, Trividia Health. This report intends to identify significant growth areas and to explore relevant market strategies. This in-depth analysis delves into the global market for point-of-care testing (poct). The primary goal of this research is to examine the potential growth areas, significant trends, and the market's impact on the industry. The report also reviews the adoption of point-of-care testing (poct) in both established and emerging markets.